These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 33954177

  • 61. Rapid growth is a dominant predictor of hepcidin suppression and declining ferritin in Gambian infants.
    Armitage AE, Agbla SC, Betts M, Sise EA, Jallow MW, Sambou E, Darboe B, Worwui A, Weinstock GM, Antonio M, Pasricha SR, Prentice AM, Drakesmith H, Darboe MK, Kwambana-Adams BA.
    Haematologica; 2019 Aug; 104(8):1542-1553. PubMed ID: 30733275
    [Abstract] [Full Text] [Related]

  • 62. Hepcidin gene polymorphisms and iron overload in β-thalassemia major patients refractory to iron chelating therapy.
    Zarghamian P, Azarkeivan A, Arabkhazaeli A, Mardani A, Shahabi M.
    BMC Med Genet; 2020 Apr 08; 21(1):75. PubMed ID: 32268883
    [Abstract] [Full Text] [Related]

  • 63. [Biological diagnosis of iron deficiency in children].
    Thuret I.
    Arch Pediatr; 2017 May 08; 24(5S):5S6-5S13. PubMed ID: 28622783
    [Abstract] [Full Text] [Related]

  • 64. Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells.
    Tanno T, Porayette P, Sripichai O, Noh SJ, Byrnes C, Bhupatiraju A, Lee YT, Goodnough JB, Harandi O, Ganz T, Paulson RF, Miller JL.
    Blood; 2009 Jul 02; 114(1):181-6. PubMed ID: 19414861
    [Abstract] [Full Text] [Related]

  • 65. Sickle Cell and α+-Thalassemia Traits Influence the Association between Ferritin and Hepcidin in Rural Kenyan Children Aged 14-26 Months.
    Byrd KA, Williams TN, Lin A, Pickering AJ, Arnold BF, Arnold CD, Kiprotich M, Dentz HN, Njenga SM, Rao G, Colford JM, Null C, Stewart CP.
    J Nutr; 2018 Dec 01; 148(12):1903-1910. PubMed ID: 30517728
    [Abstract] [Full Text] [Related]

  • 66. Iron status in patients with pyruvate kinase deficiency: neonatal hyperferritinaemia associated with a novel frameshift deletion in the PKLR gene (p.Arg518fs), and low hepcidin to ferritin ratios.
    Mojzikova R, Koralkova P, Holub D, Zidova Z, Pospisilova D, Cermak J, Striezencova Laluhova Z, Indrak K, Sukova M, Partschova M, Kucerova J, Horvathova M, Divoky V.
    Br J Haematol; 2014 May 01; 165(4):556-63. PubMed ID: 24533562
    [Abstract] [Full Text] [Related]

  • 67. Standardized serum hepcidin values in Dutch children: Set point relative to body iron changes during childhood.
    Donker AE, Galesloot TE, Laarakkers CM, Klaver SM, Bakkeren DL, Swinkels DW.
    Pediatr Blood Cancer; 2020 Mar 01; 67(3):e28038. PubMed ID: 31724793
    [Abstract] [Full Text] [Related]

  • 68. Study of serum hepcidin in hereditary hemolytic anemias.
    El Beshlawy A, Alaraby I, Abdel Kader MS, Ahmed DH, Abdelrahman HE.
    Hemoglobin; 2012 Mar 01; 36(6):555-70. PubMed ID: 23088733
    [Abstract] [Full Text] [Related]

  • 69. Luspatercept stimulates erythropoiesis, increases iron utilization, and redistributes body iron in transfusion-dependent thalassemia.
    Garbowski MW, Ugidos M, Risueño A, Shetty JK, Schwickart M, Hermine O, Porter JB, Thakurta A, Vodala S.
    Am J Hematol; 2024 Feb 01; 99(2):182-192. PubMed ID: 37782758
    [Abstract] [Full Text] [Related]

  • 70. Increased serum iron in preeclamptic women is likely due to low hepcidin levels.
    Brunacci F, Rocha VS, De Carli E, Espósito BP, Ruano R, Colli C.
    Nutr Res; 2018 May 01; 53():32-39. PubMed ID: 29685625
    [Abstract] [Full Text] [Related]

  • 71. Serum hepcidin levels are related to serum markers for iron metabolism and fibrosis stage in patients with chronic hepatitis B: A cross-sectional study.
    Çam H, Yılmaz N.
    Arab J Gastroenterol; 2020 Jun 01; 21(2):85-90. PubMed ID: 32423859
    [Abstract] [Full Text] [Related]

  • 72. Adaptation of iron transport and metabolism to acute high-altitude hypoxia in mountaineers.
    Goetze O, Schmitt J, Spliethoff K, Theurl I, Weiss G, Swinkels DW, Tjalsma H, Maggiorini M, Krayenbühl P, Rau M, Fruehauf H, Wojtal KA, Müllhaupt B, Fried M, Gassmann M, Lutz T, Geier A.
    Hepatology; 2013 Dec 01; 58(6):2153-62. PubMed ID: 23787477
    [Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. Hepcidin levels in children with chronic liver disease.
    Cakir M, Erduran E, Turkmen ES, Aliyazicioglu Y, Reis GP, Cobanoglu U, Demir S.
    Saudi J Gastroenterol; 2015 Dec 01; 21(5):300-5. PubMed ID: 26458857
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. Hepcidin in beta-thalassemia.
    Nemeth E.
    Ann N Y Acad Sci; 2010 Aug 01; 1202():31-5. PubMed ID: 20712769
    [Abstract] [Full Text] [Related]

  • 78. Analysis of Glycosylation Profiles of Serum Glycoprotein from Iron Overload Thalassemia.
    Huang A, Huang C, Zhang M, Zhu X, Qin X.
    Clin Lab; 2018 Jul 01; 64(7):1279-1287. PubMed ID: 30146840
    [Abstract] [Full Text] [Related]

  • 79. Changes in hepcidin and reticulocyte hemoglobin equivalent levels in response to continuous erythropoietin receptor activator administration in hemodialysis patients: a randomized study.
    Kakimoto-Shino M, Toya Y, Kuji T, Fujikawa T, Umemura S.
    Ther Apher Dial; 2014 Oct 01; 18(5):421-6. PubMed ID: 24456328
    [Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.